The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Involvement of Human Micro-RNA in Growth and Response to Chemotherapy in Human Cholangiocarcinoma Cell Lines
Open accessAbstract
Background & aims Micro-RNA (miRNA) are endogenous regulatory RNA molecules that modulate gene expression. Alterations in miRNA expression can contribute to tumor growth by modulating the functional expression of critical genes involved in tumor cell proliferation or survival. Our aims were to identify specific miRNA involved in the regulation of cholangiocarcinoma growth and response to chemotherapy. Methods miRNA expression in malignant and nonmalignant human cholangiocytes was assessed using a microarray. Expression of selected miRNA and their precursors was evaluated by Northern blots and real-time polymerase chain reaction, respectively. The effect of selected miRNA on cell growth and response to chemotherapy was assessed using miRNA-specific antisense oligonucleotides to decrease miRNA expression or with precursor miRNA to increase cellular expression. Results miRNA expression was markedly different in malignant cholangiocytes, with decreased expression of many miRNA compared with nonmalignant cells. A cluster of miRNA, including miR-320, miR-200b, miR-21, miR-23a, miR-141, miR-27a, and miR-34a, were expressed in all cell lines. MiR-21, miR-141, and miR-200b were highly over-expressed in malignant cholangiocytes. Inhibition of miR-21 and miR-200b increased sensitivity to gemcitabine, whereas inhibition of miR-141 decreased cell growth. Treatment of tumor cell xenografts with systemic gemcitabine altered the expression of a significant number of miRNA. miR-21 modulates gemcitabine-induced apoptosis by phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-dependent activation of PI 3-kinase signaling. Potential target genes that were modulated by selected miRNA were identified. Conclusions Alterations in miRNA expression contribute to tumor growth and response to chemotherapy. Aberrantly expressed miRNA or their targets will provide mechanistic insight and therapeutic targets for cholangiocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Three miR-21 targets have, thus far, been described: phosphatase and tensin homologue (PTEN), programmed cell death 4 (PDCD4) and Tropomyosin 1 (TPM1; refs.10,[14][15][16].”
From MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells (2008) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
TM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando, E., Mu, D., Goodson, S. G., Powers, S., Cordon‐Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,642
An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans
Lau, N. C., Lim, L. P., Weinstein, E. G., & Bartel, D. P. (2001) · Science · doi:10.1126/science.1065062 · Cited by 3,345
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,782
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., & Sarnow, P. (2005) · Science · doi:10.1126/science.1113329 · Cited by 2,580
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Self-citation
Cited by
Sorted by citations
Items 501–600 of 983
The integrative knowledge base for miRNA-mRNA expression in colorectal cancer
Skok, D. J., Hauptman, N., Boštjančič, E., & Zidar, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-54358-w · Cited by 23
The Role of microRNA in Head and Neck Cancer: Current Knowledge and Perspectives
Courthod, G., Franco, P., Palermo, L., Pisconti, S., & Numico, G. (2014) · Molecules · doi:10.3390/molecules19055704 · Cited by 42
MicroRNAs in Hepatobiliary and Pancreatic Cancers
Saito, Y., Suzuki, H., Matsuura, M., Sato, A., Kasai, Y., Yamada, K., Saito, H., & Hibi∥, T. (2011) · Frontiers in Genetics · doi:10.3389/fgene.2011.00066 · Cited by 42
Decreased Expression of MicroRNA-375 in Nonsmall Cell Lung Cancer and its Clinical Significance
Li, Y., Jiang, Q., Xia, N., Yang, H., & Hu, C. (2012) · Journal of International Medical Research · doi:10.1177/030006051204000505 · Cited by 42
Quan, J., Pan, X., Li, Y., Hu, Y., Tao, L., Li, Z., Zhao, L., Wang, J., Li, H., Lai, Y., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.065 · Cited by 42
RetractedWilmott, J. S., Zhang, X. D., Hersey, P., & Scolyer, R. A. (2011) · Pathology · doi:10.1097/pat.0b013e32834a7358 · Cited by 41
Kitamura, T., Connolly, K., Ruffino, L., Ajiki, T., Lueckgen, A., DiGiovanni, J., & Kiguchi, K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.018 · Cited by 41
Cui, M., Yao, X., Yang, L., Zhang, D., Cui, R., & Zhang, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28958 · Cited by 40
Egidi, M. G., Cochetti, G. G., Serva, M. R., Guelfi, G., Zampini, D., Mechelli, L., & Mearini, E. E. (2013) · BioMed Research International · doi:10.1155/2013/241780 · Cited by 40
Plieskatt, J. L., Rinaldi, G., Feng, Y., Peng, J., Easley, S., Jia, X., Potriquet, J., Pairojkul, C., Bhudhisawasdi, V., Sripa, B., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1270-5 · Cited by 40
McNally, M. E., Collins, A., Wojcik, S. E., Liu, J., Henry, J. C., Jiang, J., Schmittgen, T. D., & Bloomston, M. (2012) · HPB · doi:10.1111/j.1477-2574.2012.00523.x · Cited by 40
Self-citationDownregulation of miR-21 increases cisplatin sensitivity of non–small-cell lung cancer
Xu, L., Huang, Y., Chen, D., He, J.-Y., Zhu, W., Zhang, Y., & Liu, X. (2014) · Cancer Genetics · doi:10.1016/j.cancergen.2014.04.003 · Cited by 42
Hu, A., Huang, J., Xu, W., Jin, X., Li, J., Tang, Y., Huang, X., Cui, H.-J., Sun, G., Li, R., et al. (2015) · Europe PMC (PubMed Central) · Cited by 40
MicroRNA Maturation and Human Disease
Hesse, M., & Arenz, C. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-703-7_2 · Cited by 40
Lü, H., Lu, S., Yang, D., Zhang, L., Ye, J., Mao, L., & Hu, W. (2019) · Bioscience Reports · doi:10.1042/bsr20181374 · Cited by 40
Expression profile of MicroRNA: An Emerging Hallmark of Cancer
Zaheer, U., Faheem, M., Qadri, I., Begum, N., Yassine, H. M., Thani, A. A. A., & Mathew, S. (2019) · Current Pharmaceutical Design · doi:10.2174/1386207322666190325122821 · Cited by 39
MicroRNA-21 contributes to suppress cytokines production by targeting TLR28 in teleost fish
Bi, D., Cui, J., Chu, Q., & Xu, T. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.01.016 · Cited by 39
Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel
Jin, B. R., Liu, Y., & Wang, H. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0450-2 · Cited by 39
PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma
Khalid, A., Hussain, T., Manzoor, S., Saalim, M., & Khaliq, S. (2017) · Tumor Biology · doi:10.1177/1010428317705754 · Cited by 39
miR-671-5p Blocks The Progression Of Human Esophageal Squamous Cell Carcinoma By Suppressing FGFR2
Li, X., Nie, C., Tian, B., Tan, X. N., Han, W., Wang, J., Jin, Y., Li, Y., Guan, X., Hong, A., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.32429 · Cited by 39
MicroRNAs as Oncogenes and Tumor Suppressors
Rufino‐Palomares, E. E., Reyes‐Zurita, F. J., Lupiáñez, J. A., & Medina, P. P. (2013) · Wiley eBooks · doi:10.1002/9781118300312.ch14 · Cited by 43
Emerging fundamental roles for non-coding RNA species in toxicology
Taylor, E., & Gant, T. W. (2008) · Toxicology · doi:10.1016/j.tox.2007.12.030 · Cited by 37
Gao, W., Liu, L., Lu, X. J., & Shu, Y. (2011) · Clinical Lung Cancer · doi:10.3816/clc.2011.n.001 · Cited by 38
YANG, G., JIANG, O., LING, D., JIANG, X., YUAN, P., ZENG, G., ZHU, J., TIAN, J., WENG, Y., & WU, D. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3890 · Cited by 38
Role of the Notch signaling in cholangiocarcinoma
Cigliano, A., Wang, J., Chen, X., & Calvisi, D. F. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1310842 · Cited by 39
Zhao, W., Ning, L., Wang, L., Ouyang, T., Qi, L., Yang, R., & Wu, Y. (2021) · Andrologia · doi:10.1111/and.14016 · Cited by 39
MicroRNAs: short non-coding players in cancer chemoresistance
Donzelli, S., Mori, F., Biagioni, F., Bellissimo, T., Pulito, C., Muti, P. C., Strano, S., & Blandino, G. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-16 · Cited by 38
A six-microRNA set as prognostic indicators for bile duct cancer.
Wang, M., Wen, T., He, L., Li, C., Zhu, W.-J., & Trishul, N. M. (2015) · PubMed Central · Cited by 37
Emerging molecular targets and therapy for cholangiocarcinoma
Kayhanian, H., Smyth, E. C., & Braconi, C. (2017) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v9.i7.268 · Cited by 37
Genetic and epigenetic changes associated with cholangiocarcinoma: From DNA methylation to microRNAs
Stutes, M., Tran, S., & DeMorrow, S. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i48.6465 · Cited by 38
Liu, K., Li, G., Fan, C., Zhou, X., Wu, B., & Li, J. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900626 · Cited by 36
Clusterin Is a Gene-Specific Target of microRNA-21 in Head and Neck Squamous Cell Carcinoma
Mydlarz, W. K., Uemura, M., Ahn, S. M., Hennessey, P., Chang, S., Demokan, S., Sun, W., Shao, C., Bishop, J. A., Krosting, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2675 · Cited by 36
MicroRNAs Implicated in the Immunopathogenesis of Lupus Nephritis
Chafin, C. B., & Reilly, C. M. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/430239 · Cited by 36
Shi, L., Li, X., Wu, Z., Li, X., Nie, J., Guo, M., Mei, Q., & Han, W. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2018.04.003 · Cited by 36
Tanjak, P., Thiantanawat, A., Watcharasit, P., & Satayavivad, J. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4375 · Cited by 36
Function and mechanisms of microRNA‑20a in colorectal cancer (Review)
Zheng, X. W., Chen, S., Feng, S., Li, Y., Zou, J., Ling, H. Y., Zeng, Y., & Zeng, X. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8432 · Cited by 37
Sirica, A. E., Nathanson, M. H., Gores, G. J., & LaRusso, N. F. (2008) · Hepatology · doi:10.1002/hep.22623 · Cited by 36
Shen, L., He, J., Yang, D.-H., Ding, Y., Chen, X., Geng, Y., Liu, S., Liu, X., & Wang, Y. (2013) · Reproductive Sciences · doi:10.1177/1933719113488453 · Cited by 35
Shen, S.-F., Pan, J., Lu, X., & Chi, P. (2016) · Oncology Letters · doi:10.3892/ol.2016.5210 · Cited by 35
miR-21 increases c-kit+ cardiac stem cell proliferation in vitro through PTEN/PI3K/Akt signaling
Shi, B., Deng, W., Long, X., Zhao, R., Wang, Y., Chen, W., Xu, G., Sheng, J., Wang, D., & Cao, S. (2017) · PeerJ · doi:10.7717/peerj.2859 · Cited by 35
Du, Z., Niu, S., Xu, X., & Xu, Q. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170568 · Cited by 34
Pan, B., & Li, J. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.05.011 · Cited by 35
Qin, S., Wang, H., Liu, G., Mei, H., & Chen, M. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10779 · Cited by 35
Comprehensive review on signaling pathways of dietary saponins in cancer cells suppression
Zhou, Y., Farooqı, A. A., & Xu, B. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2000933 · Cited by 39
Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression
Li, H., Hui, L., Xu, W., Shen, H., Chen, Q., Long, L., & Zhu, X. (2012) · Pharmaceutical Biology · doi:10.3109/13880209.2012.665931 · Cited by 35
Liu, K., Liu, S., Zhang, W., Ji, B., Wang, Y., & Liu, Y. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5280 · Cited by 34
RetractedDeng, W., Wang, Y., Long, X., Zhao, R., Wang, Z., Liu, Z., Cao, S., & Shi, B. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5389181 · Cited by 34
MicroRNAs and cancer therapy: The next wave or here to stay?
Reddy, S. D. N., Gajula, R. P., Pakala, S. B., & Kumar, R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.7.11402 · Cited by 33
Sugiyama, K., Kajiyama, H., Shibata, K., Yuan, H., Kikkawa, F., & Senga, T. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0135 · Cited by 33
Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma
Liang, Z., Liu, X., Zhang, Q., Wang, C., & Zhao, Y. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.07.006 · Cited by 33
Therapeutic Potential of Autophagy Modulation in Cholangiocarcinoma
Perez‐Montoyo, H. (2020) · Cells · doi:10.3390/cells9030614 · Cited by 35
Current progress in epigenetic research for hepatocarcinomagenesis
Huang, J. J. (2009) · Science in China Series C Life Sciences · doi:10.1007/s11427-009-0014-7 · Cited by 35
Chen, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i29.3849 · Cited by 33
MicroRNA-224 Induces G1/S Checkpoint Release in Liver Cancer
An, F., Olaru, A., Mezey, E., Xie, Q., Li, L., Piontek, K., & Selaru, F. M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4091713 · Cited by 32
The role of microRNAs in liver cancer
Papaconstantinou, I., Karakatsanis, A., Gazouli, M., Polymeneas, G., & Voros, D. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283505063 · Cited by 32
Wang, B., Yang, J., & Xiao, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164105 · Cited by 32
RetractedMicroRNAs in Cancer Translational Research
Cho, W. C. S. (2011) · Springer eBooks · doi:10.1007/978-94-007-0298-1 · Cited by 32
The role of the PTEN gene in malignant gliomas
Alexiou, G. Α., & Voulgaris, S. (2010) · Neurologia i Neurochirurgia Polska · doi:10.1016/s0028-3843(14)60408-4 · Cited by 32
Nedaeinia, R., Avan, A., Ahmadian, M., Nia, S. N., Ranjbar, M., Sharifi, M., Goli, M., Piroozmand, A., Nourmohammadi, E., Manian, M., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26047 · Cited by 32
An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions
Selçuklu, S. D., Yakicier, M. C., & Erson-Bensan, A. E. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.09.009 · Cited by 33
Regulation of hepatocarcinogenesis by microRNAs
Wong, C.-M. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e595 · Cited by 31
Drugs in preclinical and early-stage clinical development for pancreatic cancer
Asuthkar, S., Rao, J. S., & Gondi, C. S. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.651124 · Cited by 31
Muñoz-Garrido, P. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i43.6189 · Cited by 31
Xie, Y., Wehrkamp, C. J., Li, J., Wang, Y., Wang, Y., Mott, J. L., & Oupický, D. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00894 · Cited by 31
Mahmoud, E. H., Fawzy, A., & Elshimy, R. A. A. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.1.33 · Cited by 31
Jusoh, A. R., Mohan, S., Ping, T. L., Din, T. A. D. A. T., Haron, J., Romli, R., Jaafar, H., Nafi, S. N. M., Salwani, T. I. T., & Yahya, M. M. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.5.1375 · Cited by 30
An emerging role for microRNAs in NF1 tumorigenesis
Sedani, A., Cooper, D. N., & Upadhyaya, M. (2012) · Human Genomics · doi:10.1186/1479-7364-6-23 · Cited by 31
MicroRNA-326 acts as a molecular switch in the regulation of midbrain urocortin 1 expression
Aschrafi, A., Verheijen, J., Gordebeke, P. M., Loohuis, N. F. M. O., Menting, K. W., Jager, A., Palkovits, M., Geenen, B., Kos, A., Martens, G. J. M., et al. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150154 · Cited by 32
The role of microRNAs involved in PI3‐kinase signaling pathway in colorectal cancer
Noorolyai, S., Mokhtarzadeh, A., Baghbani, E., Asadi, M., Baghbanzadeh, A., Moghaddam, M. M., & Baradaran, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27415 · Cited by 30
Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?
Braconi, C., Roessler, S. K., Kruk, B., Lammert, F., Krawczyk, M. J., & Andersen, J. B. (2019) · Liver International · doi:10.1111/liv.14085 · Cited by 31
Molecular mechanisms of cholangiocarcinoma
Fava, G. (2010) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v1.i1.12 · Cited by 32
Rau, C., Jeng, J. C., Jeng, S., Lu, T., Chen, Y., Liliang, P., Wu, C., Lin, C., & Hsieh, C. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-181 · Cited by 30
A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer
Waldman, S. A., & Terzic, A. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06934.x · Cited by 30
Applying small RNA molecules to the directed treatment of human diseases: realizing the potential
Pappas, T. C., Bader, A. G., Andruss, B. F., Brown, D., & Ford, L. P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.1.115 · Cited by 31
E2F1-Regulated MicroRNAs Impair TGFb-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer
Petrocca, F., Visone, R., Onelli, M. R., Shah, M. H., Nicoloso, M. S., Martino, I. D., Iliopoulos, D., Pilozzi, E., Liu, C., Negrini, M., et al. (2008) · Cited by 30
Pseudorabies viral replication is inhibited by a novel target of miR-21
Huang, J., Ma, G., Fu, L., Jia, H., Zhu, M., Li, X., & Zhao, S. (2014) · Virology · doi:10.1016/j.virol.2014.03.032 · Cited by 29
Xu, Q., Dong, Q., Sun, L. L., He, C., & Yuan, Y. (2013) · BMC Clinical Pathology · doi:10.1186/1472-6890-13-11 · Cited by 29
Integrative genomics identifies candidate microRNAs for pathogenesis of experimental biliary atresia
Bessho, K., Shanmukhappa, K. S., Sheridan, R. M., Shivakumar, P., Mourya, R., Walters, S., Kaimal, V., Dilbone, E. S., Jegga, A. G., & Bezerra, J. A. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-104 · Cited by 29
Zou, J., Zhu, X., Xiang, D., Zhang, Y., Li, J., Su, Z., Kong, L., & Zhang, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.005 · Cited by 28
Chen (2010) · Oncology Reports · doi:10.3892/or.2010.1089 · Cited by 29
Transcriptome-Wide Prediction of miRNA Targets in Human and Mouse Using FASTH
Ragan, C., Cloonan, N., Grimmond, S. M., Zuker, M., & Ragan, M. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005745 · Cited by 29
Genetic variation of miRNA sequence in pancreatic cancer
Zhu, Z., Gao, W., Qian, Z., & Miao, Y. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp023 · Cited by 29
microRNAs to Monitor Pain-migraine and Drug Treatment
Gallelli, L., Cione, E., Caroleo, M. C., Carotenuto, M., Laganà, P., Siniscalchi, A., & Guidetti, V. (2017) · MicroRNA · doi:10.2174/2211536606666170913152821 · Cited by 29
Role of microRNA in liver regeneration
Yi, P.-S., Zhang, M., & Xu, M.-Q. (2016) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/s1499-3872(15)60036-4 · Cited by 36
O’Hara, S. P., Gradilone, S. A., Masyuk, T. V., Tabibian, J. H., & LaRusso, N. F. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0048-9 · Cited by 28
Wei, J., Liu, L., Gao, W., Zhu, C., Liu, Y., Cheng, T., & Shu, Y. (2011) · Chinese Journal of Cancer Research · doi:10.1007/s11670-011-0123-2 · Cited by 28
Over-Expression of miR-21 and Lower PTEN Levels in Wilms’ Tumor with Aggressive Behavior
Cui, M., Liu, W., Zhang, L., Guo, F., Liu, Y., Chen, F., Liu, T., Ma, R., & Wu, R. (2017) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.242.43 · Cited by 28
LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p.
Xin, Y., He, X., Zhao, W., Zhan, M., Li, Y., Xiao, J., He, K., & Lu, L. (2019) · PubMed Central · Cited by 28
Zhang, S., Zhou, Y., Wang, Y., Wang, Z., Xiao, Q., Zhang, Y., Lou, Y., Qiu, Y., & Zhu, F. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa023 · Cited by 28
An update on cholangiocarcinoma associated with primary sclerosing cholangitis
Fevery, J., & Verslype, C. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328337b311 · Cited by 28
Molecular diagnosis of intrahepatic cholangiocarcinoma
Haga, H., & Patel, T. C. (2014) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.156 · Cited by 28
Self-citationmiRNAs modulate the drug response of tumor cells
Wu, X., & Xiao, H. (2009) · Science in China Series C Life Sciences · doi:10.1007/s11427-009-0114-4 · Cited by 28
Zhang, H., Li, P., Ju, H., Pešta, M., Kulda, V., Jin, W., Cai, M., Liu, C., Wu, H., Xu, J., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0598 · Cited by 28
Recent advances in the regulation of cholangiocarcinoma growth
Francis, H., Alpini, G. D., & DeMorrow, S. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00114.2010 · Cited by 29
MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors
Yang, X. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e474 · Cited by 27
Ye, L., Su, X., Wu, Z., Zheng, X., Wang, J., Chen, Z., Zhu, G., Wu, S., & Bao, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043741 · Cited by 28
Arrichiello, G., Nacca, V., Paragliola, F., & Giunta, E. F. (2022) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2022.00087 · Cited by 27
Palumbo, T., Poultsides, G. A., Kouraklis, G., Liakakos, T., Drakaki, A., Peros, G., Hatziapostolou, M., & Iliopoulos, D. (2016) · BMC Cancer · doi:10.1186/s12885-016-2384-0 · Cited by 27
Li, C., Xu, B., Miu, X., Deng, Z., Liao, H., & Hao, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5477 · Cited by 27
Zou, Y., Li, R., Kuang, D., Zuo, M., Li, W., Tong, W., Jiang, L., Zhou, M., Chen, Y., Gong, W.-C., et al. (2020) · BioMed Research International · doi:10.1155/2020/5846938 · Cited by 27
Metadata
- Authors
- Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T.
- Affiliations
- Texas A&M University System (US)
- Johns Hopkins University (US)
- The Ohio State University (US)
- Corresponding author
- Patel, Tushar
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 130
- Issue
- 7
- Pages
- 2113-2129
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1990645475
- Cited by
- 984
- References
- 44
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 13 · 2023: 24 · 2022: 26 · 2021: 27 · 2020: 22 · 2019: 28 · 2018: 27 · 2017: 49 · 2016: 60 · 2015: 64 · 2014: 86 · 2013: 76 · 2012: 65
- FWCI
- 27.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- OakTrust (Texas A&M University Libraries) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-069370, R01DK069370)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- microRNA, cholangiocarcinoma, miR-21, miR-200b, miR-141, gemcitabine, chemotherapy response, tumor cell proliferation, PTEN, PI3K signaling, apoptosis, miRNA expression profiling, cholangiocytes, xenografts, therapeutic target
- MeSH terms
- Gemcitabine, Animals, Deoxycytidine, Humans, Male, Mice, Nude, Probability, Sampling Studies, Sensitivity and Specificity, Transfection, Transplantation, Heterologous, Blotting, Northern, Blotting, Western, Gene Expression Regulation, Neoplastic, Apoptosis, Cholangiocarcinoma, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, MicroRNAs, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
